XML 49 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Information
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Information
Note 22 – Segment Information
See Note 1 to the Consolidated Financial Statements for a description of our segments. A description of our basis for reporting segment operating results is outlined below. Intersegment revenues primarily reflect pharmacy and care services transactions between the Evernorth Health Services and Cigna Healthcare segments. The Chairman and Chief Executive Officer is the chief operating decision maker ("CODM") responsible for making decisions about resources to be allocated to the segment and assessing its performance.
The Company uses "pre-tax adjusted income (loss) from operations" and "adjusted revenues" as its principal financial measures of segment operating performance because management, including the CODM, believes these metrics reflect the underlying results of business operations and facilitate analysis of trends in underlying revenue, expenses and profitability to enable resource allocation decisions. We define pre-tax adjusted income (loss) from operations as income (loss) before income taxes excluding pre-tax income (loss) attributable to noncontrolling interests, net investment gains/losses, amortization of acquired intangible assets and special items. The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting are also excluded. Special items are matters that management, including the CODM, believes are not representative of the underlying results of operations due to their nature or size. Adjusted income (loss) from operations is measured on an after-tax basis for consolidated results and on a pre-tax basis for segment results.
The Company defines adjusted revenues as total revenues excluding the following adjustments: special items and The Cigna Group's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. Special items are matters that management, including the CODM, believes are not representative of the underlying results of operations due to their nature or size. We exclude these items from this measure because management, including the CODM, believes they are not indicative of past or future underlying performance of the business.
The Company does not report total assets by segment because this is not a metric used by the CODM to allocate resources or evaluate segment performance.
The following table presents the special items charges (benefits) recorded by the Company, as well as the respective financial statement line items impacted:
For the Years Ended December 31,
202420232022
(In millions)Pre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-tax
Integration and transaction-related costs
 (Selling, general and administrative expenses)		$275 $211 $45 $35 $135 $103 
Impairment of dividend receivable
 (Net investment income)		182 138 — — — — 
Deferred tax expenses (benefits), net
 (Income taxes, less amount attributable to noncontrolling interests)		— 84 — (1,071)— — 
Net (gain) loss on sale of businesses(24)(2)1,499 1,429 (1,662)(1,332)
Charge for organizational efficiency plan
 (Selling, general and administrative expenses)		— — 252 193 22 17 
Charges (benefits) associated with litigation matters
 (Selling, general and administrative expenses)		— — 201 171 (28)(20)
Total impact from special items$433 $431 $1,997 $757 $(1,533)$(1,232)
Summarized segment financial information was as follows:
(In millions)
Evernorth Health Services
Cigna Healthcare
Other Operations
Corporate and Eliminations
Total
2024
Revenues from external customers$198,177 $47,528 $440 $3 $246,148 
Intersegment revenues3,775 4,972 79 (8,826)
Net investment income
21 618 309 25 973 
Total revenues201,973 53,118 828 (8,798)247,121 
Net investment results from certain equity method investments
— (204)— — (204)
Special item related to impairment of dividend receivable182 — — — 182 
Adjusted revenues$202,155 $52,914 $828 $(8,798)$247,099 
Pharmacy and other service costs190,968 — 
Medical costs— 37,887 
Selling, general and administrative expenses3,779 10,805 
Other segment items (1)
   Interest (expense) and other(2)7 
   Less income attributable to noncontrolling interests405 — 
Pre-tax adjusted income (loss) from operations7,001 4,229 (9)(1,688)9,533 
Income (loss) before income taxes
$3,929 $3,315 $(12)$(1,963)$5,269 
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests
(405)— — — (405)
Net investment losses (2)
2,129 401 3 — 2,533 
Amortization of acquired intangible assets1,662 41 — — 1,703 
Special items
Integration and transaction-related costs— — — 275 275 
Impairment of dividend receivable 182 — — — 182 
(Gain) loss on sale of businesses(496)472 — — (24)
Pre-tax adjusted income (loss) from operations$7,001 $4,229 $(9)$(1,688)$9,533 
Other Segment Information
Depreciation and amortization$2,319 $417 $9 $30 $2,775 
(1)Other segment items represent the difference between segment adjusted revenues less significant segment expenses and pre-tax adjusted income (loss) from operations, and they do not represent significant segment items relative to the CODM's review and oversight.
(2)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.
(In millions)
Evernorth Health Services
Cigna Healthcare
Other Operations
Corporate and Eliminations
Total
2023
Revenues from external customers $147,588 $46,219 $291 $1 $194,099 
Intersegment revenues5,670 4,332 — (10,002)
Net investment income
241 597 305 23 1,166 
Total revenues153,499 51,148 596 (9,978)195,265 
Net investment results from certain equity method investments— 57 — — 57 
Adjusted revenues$153,499 $51,205 $596 $(9,978)$195,322 
Pharmacy and other service costs143,571 — 
Medical costs— 35,678 
Selling, general and administrative expenses3,340 11,055 
Other segment items (1)
Interest (expense) and other(2)8 
Less income attributable to noncontrolling interests144 2 
Pre-tax adjusted income (loss) from operations6,442 4,478 96 (1,698)9,318 
Income (loss) before income taxes
$4,768 $2,664 $76 $(1,995)$5,513 
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests
(144)(2)— — (146)
Net investment losses (2)
— 133 2 — 135 
Amortization of acquired intangible assets1,774 45 — — 1,819 
Special items
Integration and transaction-related costs
— — — 45 45 
Loss on sale of businesses
— 1,481 18 — 1,499 
Charge for organizational efficiency plan
— — — 252 252 
Charges associated with litigation matters
44 157 — — 201 
Pre-tax adjusted income (loss) from operations$6,442 $4,478 $96 $(1,698)$9,318 
Other Segment Information
Depreciation and amortization$2,438 $569 $3 $25 $3,035 
(1)Other segment items represent the difference between segment adjusted revenues less significant segment expenses and pre-tax adjusted income (loss) from operations, and they do not represent significant segment items relative to the CODM's review and oversight.
(2)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.
(In millions)
Evernorth Health Services
Cigna Healthcare
Other Operations
Corporate and Eliminations
Total
2022
Revenues from external customers$135,786 $41,738 $1,839 $— $179,363 
Intersegment revenues4,463 2,535 — (6,998)
Net investment income
86 638 424 7 1,155 
Total revenues140,335 44,911 2,263 (6,991)180,518 
Net investment results from certain equity method investments— 126 — — 126 
Adjusted revenues$140,335 $45,037 $2,263 $(6,991)$180,644 
Pharmacy and other service costs131,284 — 
Medical costs— 31,119 
Selling, general and administrative expenses2,856 9,827 
Other segment items (1)
Interest (expense) and other(2)12 
Less income attributable to noncontrolling interests66 4 
Pre-tax adjusted income (loss) from operations6,127 4,099 509 (1,466)9,269 
Income (loss) before income taxes
$4,421 $3,470 $2,101 $(1,595)$8,397 
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests
(66)(4)(14)— (84)
Net investment losses (2)
— 530 83 — 613 
Amortization of acquired intangible assets1,772 103 1 — 1,876 
Special items
Integration and transaction-related costs— — — 135 135 
(Gain) on sale of businesses— — (1,662)— (1,662)
Charge for organizational efficiency plan— — — 22 22 
(Benefits) associated with litigation matters— — — (28)(28)
Pre-tax adjusted income (loss) from operations$6,127 $4,099 $509 $(1,466)$9,269 
Other Financial Information
Depreciation and amortization$2,283 $638 $6 $10 $2,937 
(1)Other segment items represent the difference between segment adjusted revenues less significant segment expenses and pre-tax adjusted income (loss) from operations, and they do not represent significant segment items relative to the CODM's review and oversight.
(2)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.
Revenue from external customers includes Pharmacy revenues, Premiums and Fees and other revenues. The following table presents these revenues by product, premium and service type:
For the Years Ended December 31,
(In millions)202420232022
Products (Pharmacy revenues) (ASC 606)
Network revenues$105,340 $67,514 $64,946 
Home delivery and specialty revenues72,476 65,732 61,283 
Other revenues11,545 9,047 6,753 
Total Evernorth Health Services
189,361 142,293 132,982 
Other Operations
60 — — 
Corporate and eliminations(4,059)(5,050)(4,416)
Total Pharmacy revenues
185,362 137,243 128,566 
Insurance premiums (ASC 944)
Cigna Healthcare
U.S. Healthcare
Employer insured17,576 16,490 15,199 
Medicare Advantage8,679 8,771 7,896 
Stop loss6,744 6,143 5,461 
Individual and Family Plans3,951 5,088 2,636 
Other4,938 4,095 3,996 
U.S. Healthcare
41,888 40,587 35,188 
International Health3,624 3,295 2,906 
Total Cigna Healthcare45,512 43,882 38,094 
Divested International businesses— — 1,596 
Other Operations excluding Divested International businesses380 281 225 
Corporate and eliminations104 74 1 
Total Premiums
45,996 44,237 39,916 
Services (Fees) (ASC 606) and Other revenues (1)
Evernorth Health Services
12,591 10,965 7,267 
Cigna Healthcare
6,988 6,669 6,179 
Other Operations
79 10 18 
Corporate and eliminations(4,868)(5,025)(2,583)
Total Fees and other revenues (1)
14,790 12,619 10,881 
Total revenues from external customers$246,148 $194,099 $179,363 
(1)Other revenues for the years ended December 31, 2024, 2023 and 2022 were $584 million, $210 million and $168 million, respectively.
Major Customers. Revenues from a single pharmacy benefit client were approximately 16% of consolidated revenues for the year ended December 31, 2024. These amounts were reported in the Evernorth Health Services segment.

Additionally, revenues from U.S. Federal Government agencies, under a number of contracts, were approximately 11%, 15% and 14% of consolidated revenues for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts were reported in the Evernorth Health Services and Cigna Healthcare segments.
U.S. and Foreign Revenues. U.S. and foreign revenues from external customers are shown below. The Company's foreign revenues are generated by its foreign operating entities. In the periods shown, no single foreign country contributed more than 2% of consolidated revenues from external customers.
For the Years Ended December 31,
(In millions)202420232022
United States$241,563 $189,840 $174,540 
Foreign countries (1)
4,585 4,259 4,823 
Total revenues from external customers$246,148 $194,099 $179,363 
(1) In 2022, included revenues from the divested International businesses of $1.6 billion.